The International Panel Physicians Association has endorsed Qiagen's QuantiFeron-TB Gold Plus test for immigration medical screening for latent tuberculosis.
ioMérieux this week released consolidated financial statements for the year ended Dec. 31, 2017, confirming the earnings it reported in January.
Ascendas will develop and commercialize molecular diagnostic systems and assays using certain of Fluidigm's microfluidic technologies.
